Agomelatine ameliorates doxorubicin-induced cortical and hippocampal brain injury via inhibition of TNF-alpha/NF-kB pathway

References

• Aebi H. 1984. Catalase in vitro. Methods Enzymol. 105:121–126. doi: 10.1016/s0076-6879(84)05016-3.
   PubMed Web of Science ®Google Scholar
• Akbaribazm M, Khazaei MR, Khazaei F, Khazaei M. 2020. Doxorubicin and Trifolium pratense L. (Red clover) extract synergistically inhibits brain and lung metastases in 4T1 tumor-bearing BALB/c mice. Food Sci Nutr. 8(10):5557–5570. doi: 10.1002/fsn3.1820.
   PubMed Web of Science ®Google Scholar
• Alsaud MM, Alhowail AH, Aldubayan MA, Almami IS. 2023. The ameliorative effect of pioglitazone against neuroinflammation caused by doxorubicin in rats. Molecules. 28(12):4775. doi: 10.3390/molecules28124775.
   PubMed Web of Science ®Google Scholar
• Aslankoc R, Ozmen O, Yalcın A. 2022. Astaxanthin ameliorates damage to the cerebral cortex, hippocampus and cerebellar cortex caused by methotrexate. Biotech Histochem. 97(5):382–393. doi: 10.1080/10520295.2021.2004616.
   PubMed Web of Science ®Google Scholar
• Aygun H, Gul SS. 2019a. Protective effect of melatonin and agomelatine on adriamycin-induced nephrotoxicity in rat model: a renal scintigraphy and biochemical study. Bratisl Lek Listy. 120(2):113–118. doi: 10.4149/BLL_2019_018.
   PubMed Web of Science ®Google Scholar
• Aygun H, Gul SS. 2019b. Cardioprotective effect of melatonin and agomelatine on doxorubicin-induced cardiotoxicity in a rat model: an electrocardiographic, scintigraphic and biochemical study. Bratisl Lek Listy. 120(4):249–255. doi: 10.4149/BLL_2019_045.
   PubMed Web of Science ®Google Scholar
• De Berardis D, Fornaro M, Serroni N, Campanella D, Rapini G, Olivieri L, Srinivasan V, Iasevoli F, Tomasetti C, De Bartolomeis A, et al. 2015. Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression. Int J Mol Sci. 16(1):1111–1130. doi: 10.3390/ijms16011111.
   PubMed Web of Science ®Google Scholar
• de Bodinat C, Guardiola-Lemaitre B, Mocaër E, Renard P, Muñoz C, Millan MJ. 2010. Agomelatine, the first melatonergic antidepressant: discovery, characterization and development. Nat Rev Drug Discov. 9(8):628–642. doi: 10.1038/nrd3140.
   PubMed Web of Science ®Google Scholar
• Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72(1–2):248–254. doi: 10.1006/abio.1976.9999.
   PubMed Web of Science ®Google Scholar
• Camara ML, Corrigan F, Jaehne EJ, Jawahar MC, Anscomb H, Koerner H, Baune BT. 2013. TNF-α and its receptors modulate complex behaviours and neurotrophins in transgenic mice. Psychoneuroendocrinology [Internet]. 38(12):3102–3114. doi: 10.1016/j.psyneuen.2013.09.010.
   PubMed Web of Science ®Google Scholar
• Carvalho C, Santos RX, Cardoso S, Correia S, Oliveira PJ, Santos MS, Moreira PI. 2009. Doxorubicin: the good, the bad and the ugly effect. Curr Med Chem. 16(25):3267–3285. doi: 10.2174/092986709788803312.
   PubMed Web of Science ®Google Scholar
• Chen F, Chen S, Liu J, Amin N, Jin W, Fang M. 2021. Agomelatine softens depressive-like behavior through the regulation of autophagy and apoptosis. Biomed Res Int. 2021:6664591. doi: 10.1155/2021/6664591.
   PubMed Web of Science ®Google Scholar
• Chumboatong W, Khamchai S, Tocharus C, Govitrapong P, Tocharus J. 2020. Agomelatine protects against permanent cerebral ischaemia via the Nrf2-HO-1 pathway. Eur J Pharmacol. 874:173028. doi: 10.1016/j.ejphar.2020.173028.
   PubMed Web of Science ®Google Scholar
• Chunchai T, Arinno A, Ongnok B, Pantiya P, Khuanjing T, Prathumsap N, Maneechote C, Chattipakorn N, Chattipakorn SC. 2022. Ranolazine alleviated cardiac/brain dysfunction in doxorubicin-treated rats. Exp Mol Pathol. 127:104818. doi: 10.1016/j.yexmp.2022.104818.
   PubMed Web of Science ®Google Scholar
• Cooper I, Last D, Ravid O, Rand D, Matsree E, Omesi L, Shemesh C, Liberman M, Zach L, Furman O, et al. 2023. BBB opening by low pulsed electric fields, depicted by delayed-contrast MRI, enables efficient delivery of therapeutic doxorubicin doses into mice brains. Fluids Barriers CNS. 20(1):67. doi: 10.1186/s12987-023-00468-7.
   PubMed Web of Science ®Google Scholar
• Dil E, Topcu A, Mercantepe T, Tumkaya L, Akyildiz K, Saral S, Yilmaz A. 2023. Agomelatine on cisplatin-induced nephrotoxicity via oxidative stress and apoptosis. Naunyn Schmiedebergs Arch Pharmacol. 396(10):2753–2764. doi: 10.1007/s00210-023-02632-0.
   PubMed Web of Science ®Google Scholar
• Draper HH, Hadley M. 1990. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. 186:421–431. doi: 10.1016/0076-6879(90)86135-i.
   PubMed Web of Science ®Google Scholar
• El-Agamy DS, El-Harbi KM, Khoshhal S, Ahmed N, Elkablawy MA, Shaaban AA, Abo-Haded HM. 2019. Pristimerin protects against doxorubicin-induced cardiotoxicity and fibrosis through modulation of Nrf2 and MAPK/NF-kB signaling pathways. Cancer Manag Res. 11:47–61. doi: 10.2147/CMAR.S186696.
   PubMed Web of Science ®Google Scholar
• Eraslan E, Tanyeli A, Güler MC, Kurt N, Yetim Z. 2020. Agomelatine prevents indomethacin-induced gastric ulcer in rats. Pharmacol Rep. 72(4):984–991. doi: 10.1007/s43440-019-00049-2.
   PubMed Web of Science ®Google Scholar
• Faridvand Y, Haddadi P, Vahedian V, Nozari S, Nejabati HR, Pezeshkian M, Afrasiabi A, Safaie N, Jodati A, Nouri M. 2020. Human amnion membrane proteins prevent doxorubicin-induced oxidative stress injury and apoptosis in Rat H9c2 cardiomyocytes. Cardiovasc Toxicol. 20(4):370–379. doi: 10.1007/s12012-020-09564-8.
   PubMed Web of Science ®Google Scholar
• Gaillard PJ, Appeldoorn CCM, Dorland R, van Kregten J, Manca F, Vugts DJ, Windhorst B, van Dongen GAMS, de Vries HE, Maussang D, et al. 2014. Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101). Velasco G, editor. PLoS One [Internet]. 9(1):e82331. doi: 10.1371/journal.pone.0082331.
   PubMed Web of Science ®Google Scholar
• Gao M, Ma H, Liu T, Cao C, Zheng Z, Tang L, Gu W, Zhang D, Sun H. 2023. Acute toxicity and genotoxicity studies on new melatonergic antidepressant GW117. Heliyon. 9(3):e14026. doi: 10.1016/j.heliyon.2023.e14026.
   PubMed Web of Science ®Google Scholar
• Hafez HM, Waz S, El-Tahawy NFG, Mohamed MZ. 2022. Agomelatine ameliorates cadmium-induced toxicity through the modification of HMGB-1/TLR-4/NFκB pathway. Toxicol Appl Pharmacol. 457:116313. doi: 10.1016/j.taap.2022.116313.
   PubMed Web of Science ®Google Scholar
• He J, Fang P, Zheng X, Wang C, Liu T, Zhang B, Wen J, Xu R-A. 2018. Inhibitory effect of celecoxib on agomelatine metabolism in vitro and in vivo. Drug Des Devel Ther. 12:513–519. doi: 10.2147/DDDT.S160316.
   PubMed Web of Science ®Google Scholar
• Inanir S, Copoglu US, Kokacya H, Dokuyucu R, Erbas O, Inanir A. 2015. Agomelatine protection in an LPS-induced psychosis-relevant behavior model. Med Sci Monit. 21:3834–3839. doi: 10.12659/msm.895505.
   PubMed Web of Science ®Google Scholar
• Jakubczyk K, Dec K, Kałduńska J, Kawczuga D, Kochman J, Janda K. 2020. Reactive oxygen species - sources, functions, oxidative damage. Pol Merkur Lekarski. 48(284):124–127.
   PubMedGoogle Scholar
• Janke LJ, Ward JM, Vogel P. 2019. Classification, scoring, and quantification of cell death in tissue sections. Vet Pathol. 56(1):33–38. doi: 10.1177/0300985818800026.
   PubMed Web of Science ®Google Scholar
• Joffre J, Hellman J. 2021. Oxidative stress and endothelial dysfunction in sepsis and acute inflammation. Antioxid Redox Signal. 35(15):1291–1307. doi: 10.1089/ars.2021.0027.
   PubMed Web of Science ®Google Scholar
• Karakuyu NF, Savran M, Candan IA, Buyukbayram HI, Erzurumlu Y. 2023. Investigation of cardioprotective effect of lercanidipine on doxorubicin-induced cardiotoxicity. Naunyn Schmiedebergs Arch Pharmacol. 396(12):3635–3645. doi: 10.1007/s00210-023-02566-7.
   PubMed Web of Science ®Google Scholar
• Mahmoud NM, Elshazly SM, Hassan AA, Soliman E. 2023. Agomelatine improves streptozotocin-induced diabetic nephropathy through melatonin receptors/SIRT1 signaling pathway. Int Immunopharmacol. 115:109646. doi: 10.1016/j.intimp.2022.109646.
   PubMed Web of Science ®Google Scholar
• Mani V, Arfeen M, Rabbani SI, Shariq A, Amirthalingam P. 2022. Levetiracetam ameliorates doxorubicin-induced chemobrain by enhancing cholinergic transmission and reducing neuroinflammation using an experimental rat model and molecular docking study. Molecules. 27(21):7364. doi: 10.3390/molecules27217364.
   PubMed Web of Science ®Google Scholar
• Molteni R, Macchi F, Zecchillo C, Dell’agli M, Colombo E, Calabrese F, Guidotti G, Racagni G, Riva MA. 2013. Modulation of the inflammatory response in rats chronically treated with the antidepressant agomelatine. Eur Neuropsychopharmacol. 23(11):1645–1655. doi: 10.1016/j.euroneuro.2013.03.008.
   PubMed Web of Science ®Google Scholar
• Montgomery MD, Chan T, Swigart PM, Myagmar B, Dash R, Simpson PC. 2017. An alpha-1A adrenergic receptor agonist prevents acute doxorubicin cardiomyopathy in male mice. PLoS One. 12(1):e0168409. doi: 10.1371/journal.pone.0168409.
   PubMed Web of Science ®Google Scholar
• Olmos G, Lladó J. 2014. Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity. Mediators Inflamm. 2014:861231. doi: 10.1155/2014/861231.
   PubMed Web of Science ®Google Scholar
• Peng W, Rao D, Zhang M, Shi Y, Wu J, Nie G, Xia Q. 2020. Teneligliptin prevents doxorubicin-induced inflammation and apoptosis in H9c2 cells. Arch Biochem Biophys. 683:108238. doi: 10.1016/j.abb.2019.108238.
   PubMed Web of Science ®Google Scholar
• Prasanna PL, Renu K, Valsala Gopalakrishnan A. 2020. New molecular and biochemical insights of doxorubicin-induced hepatotoxicity. Life Sci. 250:117599. doi: 10.1016/j.lfs.2020.117599.
   PubMed Web of Science ®Google Scholar
• Rebai R, Jasmin L, Boudah A. 2021. Agomelatine effects on fat-enriched diet induced neuroinflammation and depression-like behavior in rats. Biomed Pharmacother. 135:111246. doi: 10.1016/j.biopha.2021.111246.
   PubMed Web of Science ®Google Scholar
• Ren X, Keeney JTR, Miriyala S, Noel T, Powell DK, Chaiswing L, Bondada S, St Clair DK, Butterfield DA. 2019. The triangle of death of neurons: oxidative damage, mitochondrial dysfunction, and loss of choline-containing biomolecules in brains of mice treated with doxorubicin. Advanced insights into mechanisms of chemotherapy induced cognitive impairment (“chemobrain”) involving TNF-α. Free Radic Biol Med. 134:1–8. doi: 10.1016/j.freeradbiomed.2018.12.029.
   PubMed Web of Science ®Google Scholar
• Rizk HA, Masoud MA, Maher OW. 2017. Prophylactic effects of ellagic acid and rosmarinic acid on doxorubicin-induced neurotoxicity in rats. J Biochem Mol Toxicol. 31(12):e21977. doi: 10.1002/jbt.21977.
   PubMed Web of Science ®Google Scholar
• Sansone RA, Sansone LA. 2011. Agomelatine: a novel antidepressant. Innov Clin Neurosci. 8(11):10–14. http://www.ncbi.nlm.nih.gov/pubmed/22191083.
   Google Scholar
• Savran M, Aslankoc R, Ozmen O, Erzurumlu Y, Savas HB, Temel EN, Kosar PA, Boztepe S. 2020. Agomelatine could prevent brain and cerebellum injury against LPS-induced neuroinflammation in rats. Cytokine. 127:154957. doi: 10.1016/j.cyto.2019.154957.
   PubMed Web of Science ®Google Scholar
• Savran M, Ozmen O, Erzurumlu Y, Savas HB, Asci S, Kaynak M. 2019. The impact of prophylactic lacosamide on LPS-induced neuroinflammation in aged rats. Inflammation. 42(5):1913–1924. doi: 10.1007/s10753-019-01053-7.
   PubMed Web of Science ®Google Scholar
• Shinde M, Bali N, Rathod S, Karemore M, Salve P. 2020. Effect of binary combinations of solvent systems on permeability profiling of pure agomelatine across rat skin: a comparative study with statistically optimized polymeric nanoparticles. Drug Dev Ind Pharm. 46(5):826–845. doi: 10.1080/03639045.2020.1757697.
   PubMed Web of Science ®Google Scholar
• Srinivasan V, De Berardis D, Shillcutt SD, Brzezinski A. 2012. Role of melatonin in mood disorders and the antidepressant effects of agomelatine. Expert Opin Investig Drugs. 21(10):1503–1522. doi: 10.1517/13543784.2012.711314.
   PubMed Web of Science ®Google Scholar
• Sritharan S, Sivalingam N. 2021. A comprehensive review on time-tested anticancer drug doxorubicin. Life Sci. 278:119527. doi: 10.1016/j.lfs.2021.119527.
   PubMed Web of Science ®Google Scholar
• Woolliams JA, Wiener G, Anderson PH, McMurray CH. 1983. Variation in the activities of glutathione peroxidase and superoxide dismutase and in the concentration of copper in the blood in various breed crosses of sheep. Res Vet Sci. 34(3):253–256. http://www.ncbi.nlm.nih.gov/pubmed/6878874. doi: 10.1016/S0034-5288(18)32219-7.
   PubMed Web of Science ®Google Scholar
• Wu BB, Leung KT, Poon EN-Y. 2022. Mitochondrial-targeted therapy for doxorubicin-induced cardiotoxicity. Int J Mol Sci. 23(3):1912. doi: 10.3390/ijms23031912.
   Web of Science ®Google Scholar
• Xiang C, Yan Y, Zhang D. 2021. Alleviation of the doxorubicin-induced nephrotoxicity by fasudil in vivo and in vitro. J Pharmacol Sci. 145(1):6–15. doi: 10.1016/j.jphs.2020.10.002.
   PubMed Web of Science ®Google Scholar
• Zelová H, Hošek J. 2013. TNF-α signalling and inflammation: interactions between old acquaintances. Inflamm Res. 62(7):641–651. doi: 10.1007/s00011-013-0633-0.
   PubMed Web of Science ®Google Scholar
• Zhu L, Lin M. 2021. The synthesis of nano-doxorubicin and its anticancer effect. Anticancer Agents Med Chem. 21(18):2466–2477. doi: 10.2174/1871520621666201229115612.
   PubMed Web of Science ®Google Scholar